Editorial Comment: Temporary Withholding of Antithrombotic Therapy Before a Core Needle Breast or Axillary Biopsy Does Not Reduce the Risk of Postbiopsy Hematoma

AJR Am J Roentgenol. 2023 Oct;221(4):448. doi: 10.2214/AJR.23.29626. Epub 2023 May 17.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biopsy
  • Breast* / pathology
  • Fibrinolytic Agents* / adverse effects
  • Hematoma / diagnostic imaging
  • Hematoma / etiology
  • Hemorrhage / chemically induced
  • Hemorrhage / pathology
  • Hemorrhage / prevention & control
  • Humans

Substances

  • Fibrinolytic Agents